Effects of Combined Rectus Sheath and Ilioinguinal Nerve Block on Opioid Consumption in HALDN
NCT ID: NCT06941259
Last Updated: 2025-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2025-03-30
2025-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does combined rectus sheath block and ilioinguinal nerve block lower the amount of postoperative opioid consumption? Does reduced postoperative opioid consumption reduce the incidence of potential opioid related side effects? Does the application of nerve block affect length of hospital stay?
Researchers will compare patients who had nerve blocks with regional anaesthesia to a placebo group to see if total postoperative opioid consumption.
Participants will be randomly divided in two. Regional anaesthesia with local anaesthesia or a placebo will be performed. Patients will be followed 24 hours postoperatively to measure total opioid consumption.
Possible side effects, complications and length of hospital stay will be noted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Effect of Lidocaine Infusion Applied at Different Doses During Lumbar Spinal Surgery on Hemodynamics and Postoperative Pain
NCT05936190
Intrathecal Morphine for Inguinal Hernia Repair.
NCT02001948
Thoracic Spinal Versus Epidural Anesthesia for Nephrectomy in Obstructive/Restrictive Lung Disease Patients
NCT03324490
Comparison of Local Anesthetic Dose in Ipack Block Performed in Knee Arthroplasty Operations
NCT05963139
Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases
NCT06739460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This method is a widely used comparison method and is used to obtain a double-blind study design.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Group B: After patients anesthetized under general anaesthesia, a combined rectus sheath block and ilioinguinal nerve block will be applied with 0.25% bupivacaine.
PREVENTION
DOUBLE
The care providers will be blind to the solution when they are performing the regional anaesthesia.
The care providers will be blind when they are monitoring the patient after surgery.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Sham
After the induction of general anaesthesia, the rectus sheath block and ilioinguinal nerve block will be performed to patients with a solution containing only physiological saline.
Rectus sheath and ilioinguinal nerve block with physiological saline
Rectus sheath and ilioinguinal nerve block without local anaesthesia
Group Block
After the induction of general anaesthesia, the rectus sheath block and ilioinguinal nerve block will be performed to patients with a solution containing 0.25% bupivacaine.
Rectus sheath and ilioinguinal nerve block with local anaesthesia
Rectus sheath and ilioinguinal nerve block with local anaesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rectus sheath and ilioinguinal nerve block with physiological saline
Rectus sheath and ilioinguinal nerve block without local anaesthesia
Rectus sheath and ilioinguinal nerve block with local anaesthesia
Rectus sheath and ilioinguinal nerve block with local anaesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laparoscopic hand assisted donor nephrectomy operation is planned.
Exclusion Criteria
* Patients using chronic narcotics or narcotic receptor agonists
* Patients with psychiatric disorders
* Patients with chronic organ failure
* Patients without end organ damage
* The patients who did not give consent
* Foreign national patients
* Patients with American Society of Anaesthesiologists (ASA) physical status classification score III and above
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Koç University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasemin Sincer, MD
Role: PRINCIPAL_INVESTIGATOR
Koç University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Koç University Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ozkalayci O, Karakaya MA, Yenigun Y, Cetin S, Darcin K, Akyollu B, Arpali E, Kocak B, Gurkan Y. Effects of erector spinae plane block on opioid consumption in patients undergoing hand-assisted laparoscopic donor nephrectomy: a randomized controlled trial. Minerva Anestesiol. 2024 Mar;90(3):154-161. doi: 10.23736/S0375-9393.23.17706-6. Epub 2024 Feb 2.
Gunaydin B, Ucar T, Arpali E, Akyollu B, Akinci S, Karatas C, Oztorun K, Kocak B. Hand-assisted laparoscopic donor nephrectomy: 1864 cases in 15 years of experience. Turk J Med Sci. 2022 Aug;52(4):1322-1328. doi: 10.55730/1300-0144.5438. Epub 2022 Aug 10.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024.394.IRB1.046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.